Current Practice in Molecular Genetic Testing in NSCLC Patients in Czechia. Data from the TULUNG Registry 2011-2021.
M. Bratová (Brno, Czech Republic), K. Brat (Brno, Czech Republic), J. Skrickova (Brno, Czech Republic), K. Hurdalkova (Brno, Czech Republic), M. Pesek (Pilsen, Czech Republic), M. Svaton (Pilsen, Czech Republic), L. Havel (Prague, Czech Republic), L. Koubkova (Prague, Czech Republic), M. Hrnciarik (Hradec Kralove, Czech Republic), O. Fischer (Olomouc, Czech Republic), J. Krejci (Praque, Czech Republic)
Source: International Congress 2022 – Molecular footprints in lung cancer
Session: Molecular footprints in lung cancer
Session type: Thematic Poster
Number: 4108
 
Rating: 
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
M. Bratová (Brno, Czech Republic), K. Brat (Brno, Czech Republic), J. Skrickova (Brno, Czech Republic), K. Hurdalkova (Brno, Czech Republic), M. Pesek (Pilsen, Czech Republic), M. Svaton (Pilsen, Czech Republic), L. Havel (Prague, Czech Republic), L. Koubkova (Prague, Czech Republic), M. Hrnciarik (Hradec Kralove, Czech Republic), O. Fischer (Olomouc, Czech Republic), J. Krejci (Praque, Czech Republic). Current Practice in Molecular Genetic Testing in NSCLC Patients in Czechia. Data from the TULUNG Registry 2011-2021.. 4108
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
|
|